Today’s climate in the pharmacoeconomic arena, characterised by sinking profit margins, redistributions of market shares and increasing competition, all highlight an urgent need to identify clear strategies for the future of pharmaceutical pricing and reimbursement. SMi is proud to present its 14th Annual European Pharmaceutical Pricing and Reimbursement Conference, which will bring together the leading figures in the field to address the questions of uncertainty in the future.
Today’s climate in the pharmacoeconomic arena, characterised by sinking profit margins, redistributions of market shares and increasing competition, all highlight an urgent need to identify clear strategies for the future of pharmaceutical pricing and reimbursement. SMi is proud to present its 14th Annual European Pharmaceutical Pricing and Reimbursement Conference, which will bring together the leading figures in the field to address the questions of uncertainty in the future. Benefits of attending: Optimise your pricing and reimbursement strategy Discover the impact of parallel trade and generics Analyse how health economics and outcomes research can help to predict pricing issues Identify regional variations in pricing and reimbursement across Europe Understand how the market influences, and is influenced by pharmaceutical pricing To register online simply visit the website: www.smi-online.co.uk/08europricing18.asp